Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine

Mireia Palomar-Siles(Karolinska Institutet), Angelos Heldin(Karolinska Institutet), Meiqiongzi Zhang(Karolinska Institutet), Charlotte Strandgren(Karolinska Institutet), Viktor Yurevych(Princess Máxima Center), Jip T. van Dinter(Princess Máxima Center), Sem A.G. Engels(Princess Máxima Center), Damon A. Hofman(Princess Máxima Center), Susanne Öhlin(Karolinska Institutet), Birthe Meineke(Karolinska Institutet), Vladimir J.N. Bykov(Karolinska Institutet), Sebastiaan van Heesch(Princess Máxima Center), Klas G. Wiman(Karolinska Institutet)
Cell Death and Disease
November 25, 2022
Cited by 35Open Access
Full Text

Abstract

TP53 nonsense mutations in cancer produce truncated inactive p53 protein. We show that 5-FU metabolite 5-Fluorouridine (FUr) induces full-length p53 in human tumor cells carrying R213X nonsense mutant TP53. Ribosome profiling visualized translational readthrough at the R213X premature stop codon and demonstrated that FUr-induced readthrough is less permissive for canonical stop codon readthrough compared to aminoglycoside G418. FUr is incorporated into mRNA and can potentially base-pair with guanine, allowing insertion of Arg tRNA at the TP53 R213X UGA premature stop codon and translation of full-length wild-type p53. We confirmed that full-length p53 rescued by FUr triggers tumor cell death by apoptosis. FUr also restored full-length p53 in TP53 R213X mutant human tumor xenografts in vivo. Thus, we demonstrate a novel strategy for therapeutic rescue of nonsense mutant TP53 and suggest that FUr should be explored for treatment of patients with TP53 nonsense mutant tumors.


Related Papers

No related papers found

Powered by citation graph analysis